AI Verdict
GLRE has stronger fundamentals based on our AI analysis.
GLUC vs GLRE Fundamental Comparison
| Metric | GLUC | GLRE |
|---|---|---|
| Revenue | $72,940.0 | $729.8M |
| Net Income | $39,018.0 | $74.8M |
| Net Margin | 53.5% | 10.3% |
| ROE | N/A | 10.6% |
| ROA | 148.1% | 3.4% |
| Current Ratio | 0.06x | N/A |
| Debt/Equity | N/A | 0.01x |
| EPS | N/A | $2.17 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
GLUC vs GLRE: Frequently Asked Questions
Is GLUC or GLRE a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), GLRE has stronger fundamentals. GLUC is rated STRONG SELL (72% confidence) while GLRE is rated BUY (72% confidence). This is not investment advice.
How does GLUC compare to GLRE fundamentally?
Glucose Health, Inc. has ROE of N/A vs GREENLIGHT CAPITAL RE, LTD.'s 10.6%. Net margins are 53.5% vs 10.3% respectively.
Which stock pays higher dividends, GLUC or GLRE?
GLUC has a dividend yield of N/A or no dividend while GLRE has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in GLUC or GLRE for long term?
For long-term investing, consider that GLUC has STRONG SELL rating with 72% confidence, while GLRE has BUY rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about GLUC vs GLRE?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For GLUC vs GLRE, the AI consensus favors GLRE based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.